The 100 Most Influential Publications on Medulloblastoma: Areas of Past, Current, and Future Focus

BACKGROUND: This article is the first to identify the most influential articles on medulloblastoma using the citation analysis methodology. OBJECTIVE: To perform a bibliometric analysis of the 100 most-cited articles on medulloblastoma. METHODS: Using the Web of Science database, search criteria included the title-specific keyword medulloblastoma OR cerebellar primitive neuroectodermal tumor (PNET) OR cerebellar PNET. Publications from 1900 to 2020 labeled article, review, data set, or clinical trial were chosen and ranked based on total number of citations in descending order. Each article was evaluated based on the following variables: total citations, average citations per year, first author, institution of first author, title, publication year, country of origin, SCImago Journal Rank, and Scopus SNIP (Source Normalized Impact per Paper). RESULTS: Our search yielded 4928 articles on medulloblastoma. The 100 most-cited articles ranged from 192 to 2017 across 42 unique journals; Journal of Clinical Oncology accounted for the most publications (16%). Paul A. Northcott was first author of the most articles on the list (n = 7.7%), and the most widely cited article was Altered neural cell fates and medulloblastoma in mouse patched mutants by Goodrich et al., published in Science (1997). CONCLUSIONS: Because medulloblastoma represents the most common form of pediatric cancerous brain tumor, it is important to identify works that have significantly contributed to the body of knowledge regarding this disease. The 100 most-cited medulloblastoma articles comprise a significant collection of data regarding the histopathologic and molecular classification of medulloblastoma as well as clinical outcomes of therapeutics used to treat this disease.

Automated summary

This article conducts a bibliometric analysis of the 100 most-cited articles on medulloblastoma, identifying key contributions to the understanding of this common pediatric brain tumor. The results provide insights into the histopathologic and molecular classification of medulloblastoma, as well as the efficacy of therapeutic interventions.